Graf Acquisition Corp IV Stock Quote GFOR - Stock Price, News, Charts, Message Board, Trades

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NYSE
Graf Acquisition Corp IV (GFOR) Quote

Graf Acquisition Corp IV (GFOR)

8.30

0.00

(0.00%)

Closed September 19 4:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

8.30

Bid

-

Ask

-

Volume

-

0.00 Day's Range 0.00

5.01 52 Week Range 12.88

Market Cap

Previous Close

8.30

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

21,889,000

Dividend Yield

-

PE Ratio

-0.13

Earnings Per Share (EPS)

-3.79

Revenue

-

Net Profit

-82.95M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

nkgenbiotech.com

Headquarters

Wilmington, Delaware, USA

Founded

-

Graf Acquisition Corp IV is listed in the Biological Pds,ex Diagnstics sector of the New York Stock Exchange with ticker GFOR. The last closing price for Graf Acquisition Corp IV was $8.30. Over the last year, Graf Acquisition Corp IV shares have traded in a share price range of $ 5.01 to $ 12.88.

Graf Acquisition Corp IV currently has 21,889,000 shares outstanding. The market capitalization of Graf Acquisition Corp IV is $181.68 million. Graf Acquisition Corp IV has a price to earnings ratio (PE ratio) of -0.13.

FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	8.3	8.3	8.3	0	0	CS
4	0	0	8.3	8.3	8.3	0	0	CS
12	0	0	8.3	8.3	8.3	0	0	CS
26	0	0	8.3	8.3	8.3	0	0	CS
52	-2.82	-25.3597122302	11.12	12.88	5.01	20072	9.4753719	CS
156	-1.45	-14.8717948718	9.75	12.88	5.01	29116	9.88111799	CS
260	-1.6	-16.1616161616	9.9	12.88	5.01	28318	9.87687786	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AACTAres Acquisition Corporation II	$ 10.805 (0.00%)	0
AAC.UAres Acquisition Corporation	$ 10.81 (0.00%)	0
AACAres Acquisition Corporation	$ 10.79 (0.00%)	0
AAAlcoa Corporation	$ 34.34 (0.00%)	0
AAgilent Technologies	$ 139.01 (0.00%)	0
AACTAres Acquisition Corporation II	$ 10.805 (0.00%)	0
AAC.UAres Acquisition Corporation	$ 10.81 (0.00%)	0
AACAres Acquisition Corporation	$ 10.79 (0.00%)	0
AAAlcoa Corporation	$ 34.34 (0.00%)	0
AAgilent Technologies	$ 139.01 (0.00%)	0
AACTAres Acquisition Corporation II	$ 10.805 (0.00%)	0
AAC.UAres Acquisition Corporation	$ 10.81 (0.00%)	0
AACAres Acquisition Corporation	$ 10.79 (0.00%)	0
AAAlcoa Corporation	$ 34.34 (0.00%)	0
AAgilent Technologies	$ 139.01 (0.00%)	0

tw0122

tw0122 3 minutes ago

MiamiGent

MiamiGent 4 minutes ago

Good observation, Red.

Ms Labonte

Ms Labonte 5 minutes ago

The junkie$$ will fill em bid$$$ Let$$$$$ gooooooo$$$$$

jxyzobrien

jxyzobrien 7 minutes ago

shane s on larry pesavento 130pm

Ms Labonte

Ms Labonte 10 minutes ago

The flipper$$ will run out of ammo very quickly with massive per market pre$$ure coming $weet$$$

eagle8

eagle8 11 minutes ago

"But we would now like to do some more focused, faster path, tumor shrinkage endpoint trials. So we are, as we evaluate, I mean, we have so many opportunities in front of us now. Really, the challenge is choosing. Right? And so we we gotta steer ourselves, to the extent we can, towards that directio

QuickCash4Me

QuickCash4Me 11 minutes ago

If you think someone posting on this board is pumping/moving shares in any company, you’re delusional. The audience is so small, it can’t possibly have an impact one way or another. The only thing it can do is help someone that is following a company with their research.

I don’t und

SkeBallLarry

SkeBallLarry 14 minutes ago

"Super" Happy *BirthDay*, Capgain " .. !!

Seminole Red

Seminole Red 17 minutes ago

Trump on Gutfield last night was great.

its easy to see a communicator would make a much better President.

no notes, no teleprompter, no agenda, just down earth talking.

Zazaboy

Zazaboy 17 minutes ago

chill out, u might wake your boyfriend.

Ms Labonte

Ms Labonte 19 minutes ago

Rolled up the 30’$$$ $weet$$ $moking it like a joint$$$$$

Ms Labonte

Ms Labonte 22 minutes ago

FDA fa$t track on $tandby new$$$ $weet$$$

Stern is Bald

Stern is Bald 23 minutes ago

toohot

toohot 26 minutes ago

Thank you for your monthly BIEL post. I see you’re still banging the table!

#1 Life is 10% what happens to you and 90% how you react to it.
Charles R. Swindoll
#2 If you have the facts, bang on the facts, if you have opinion bang on opinion, if you

Ms Labonte

Ms Labonte 28 minutes ago

Pre-market pressure $weet$$$$ Grab all you can at the$e level$$ a gift from heaven above$$$$$

KeepItRealistic

KeepItRealistic 29 minutes ago

$GNS no 🧠’er buy & hold for FAIR MARKET VALUE

$105m revenue 2024

Current Market Cap 19m

The revenue multiple, is a valuation metric used to estimate the value of a company based on its revenue.

In the education market, determining

KeepItRealistic

KeepItRealistic 30 minutes ago

$GNS no 🧠’er buy & hold for FAIR MARKET VALUE

$105m revenue 2024

Current Market Cap 19m

The revenue multiple, is a valuation metric used to estimate the value of a company based on its revenue.

In the education market, determining

Ms Labonte

Ms Labonte 30 minutes ago

Who will take u$ to heaven $weet$$$
Bristol Myers Squibb

AstraZeneca

Merck

Novartis

Roche

AbbVie

Johnson & Johnson

Accord Healthcare

Amgen

Astellas Pharma

Copilotdog

Copilotdog 40 minutes ago

Filing to shut down American OTC this qtr. product no longer at any locations.

lovethatgreen

lovethatgreen 43 minutes ago

The 500 share trades are odd but hardly nefarious and imo the stock is trading brilliantly with traders selling and buying .

Now the topic isnt labeled corruption now it's nefarious . Lol

If there was anything nefarious going on the stock would not be trading like it i

maumar

maumar 48 minutes ago

JPM: “ Despite raising our price target to reflect more value for future product royalties, we struggle to find a strong upside case from current levels that does not rely on giving even more credit. With the stock now at $62/sh, we are moving to the sidelines and lowering our rating to reflect HALO

PC retired

PC retired 53 minutes ago

1776Rebel, you seem to be coming around to the truth. It's painful, but it is better to know than to remain under an illusion.

Graf Acquisition Corp IV

Delayed Upgrade Clock